Prognostic Clinical Score for Stage II Colon Cancer: Who Should Receive Adjuvant Chemotherapy?

被引：0
|
作者：
Tran, T. [1 ]
Ejaz, A. [1 ]
Maker, V. K. [1 ]
Maker, A. V. [1 ]
机构：
[1] Univ Illinois, Chicago, IL USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2018年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PF13
引用
收藏
页码：S149 / S149
页数：1
相关论文
共 50 条
  • [41] The Latest Update of Prognostic Factors of Stage III Colon Cancer Who Underwent Curative Operation and Postoperative Adjuvant Chemotherapy
    Yokoi, Keigo
    Naito, Masanori
    Yamashita, Keishi
    Ishii, Satoru
    Tanaka, Toshimichi
    Nishizawa, Nobuyuki
    Kojo, Ken
    Tsutsui, Atsuko
    Miura, Hirohisa
    Yamanashi, Takahiro
    Ogura, Naoto
    Sato, Takeo
    Nakamura, Takatoshi
    Watanabe, Masahiko
    INTERNATIONAL SURGERY, 2019, 104 (9-10) : 446 - 452
  • [42] Adjuvant chemotherapy for stage II colon cancer: influence of care structures' characteristics on a controversial clinical practice
    Alter, Eleonore
    Phelip, Jean-Marc
    Guilhot, Jean-Noel
    Matysiak, Michel
    Vermorel, Michel
    Roblin, Xavier
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2007, 19 (11) : 995 - 1001
  • [43] Referral patterns and adjuvant chemotherapy use in patients with stage II colon cancer
    Aitelli, C. L.
    Kirkpatrick, H. M.
    Qin, H.
    Lichliter, W. E.
    Becerra, C. R.
    McCollum, A. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [44] Adjuvant treatment of stage II colon cancer: Is there a true no-chemotherapy group?
    Martin, Robert C. G.
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (06) : 766 - 767
  • [45] Adjuvant chemotherapy guided by circulating tumour DNA in stage II colon cancer
    Ray, Katrina
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2022, 19 (08) : 488 - 488
  • [46] Age Determines Adjuvant Chemotherapy Use in Resected Stage II Colon Cancer
    Hagerty, Brendan L.
    Aversa, John G.
    Dominguez, Dana A.
    Davis, Jeremy L.
    Hernandez, Jonathan M.
    McCormick, James T.
    Blakely, Andrew M.
    DISEASES OF THE COLON & RECTUM, 2022, 65 (10) : 1206 - 1214
  • [47] ADJUVANT CHEMOTHERAPY IN HIGH-RISK STAGE II COLON CANCER.
    Lightner, A.
    Glyn, T.
    Parker, M.
    Tse, C.
    Abdelsattar, Z.
    Larson, D.
    Mathis, K.
    DISEASES OF THE COLON & RECTUM, 2016, 59 (05) : E293 - E293
  • [48] Patterns of adjuvant chemotherapy for stage II and III colon cancer in France and Italy
    Bouvier, Anne-Marie
    Minicozzi, Pamela
    Grosclaude, Pascale
    Bouvier, Veronique
    Faivre, Jean
    Sant, Milena
    DIGESTIVE AND LIVER DISEASE, 2013, 45 (08) : 687 - 691
  • [49] Adjuvant Chemotherapy Is Associated With Improved Survival in Patients With Stage II Colon Cancer
    Casadaban, Leigh
    Rauscher, Garth
    Aklilu, Mebea
    Villenes, Dana
    Freels, Sally
    Maker, Ajay V.
    CANCER, 2016, 122 (21) : 3277 - 3287
  • [50] THE EFFECT OF ADJUVANT CHEMOTHERAPY ON OVERALL SURVIVAL OF STAGE II AND III COLON CANCER
    Sekkate, Sakina
    Abahssain, Halima
    Serji, Badr
    Boutayeb, Saber
    Mrabti, Hind
    Errihani, Hassan
    ANNALS OF ONCOLOGY, 2011, 22 : v88 - v88
12345